1Suppliers
11Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

NewcelX Ltd. (NCEL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

16Total relationships
2Distinct source URLs
5High confidence
0.767Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

NewcelX Ltd. Suppliers

TickerNameConfidenceEvidence
THIRD-PARTIES THIRD-PARTIES 85% NewcelX sources components of its technology from third parties and certain components are sole sourced.

NewcelX Ltd. Customers

TickerNameConfidenceEvidence
BWAY BrainsWay Ltd. 72% oodwill Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in a business combination. We operate as a single reporting unit and test goodwill…
BWAY BrainsWay Ltd. 72% Reciprocal relationship from BWAY graph: Reciprocal relationship from NCEL graph: Reciprocal relationship from BWAY graph: Reciprocal relationship from NCEL graph: Reciprocal relationship from BWAY g…
ELDN Eledon Pharmaceuticals, Inc. 72% Reciprocal relationship from ELDN graph: Reciprocal relationship from NCEL graph: Reciprocal relationship from ELDN graph: Reciprocal relationship from NCEL graph: gulatory authority approvals to do …
ELDN Eledon Pharmaceuticals, Inc. 72% gulatory authority approvals to do so. The facilities and quality systems of some or all of its collaborators and third-party contractors must pass a pre-approval inspection for compliance with the a…
INCR InterCure Ltd. 72% oodwill Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in a business combination. We operate as a single reporting unit and test goodwill…
INCR InterCure Ltd. 72% Reciprocal relationship from INCR graph: Reciprocal relationship from NCEL graph: Reciprocal relationship from INCR graph: Reciprocal relationship from NCEL graph: oodwill Goodwill represents the exc…
SVRE SaverOne 2014 Ltd. 72% Reciprocal relationship from SVRE graph: Reciprocal relationship from NCEL graph: Reciprocal relationship from SVRE graph: Reciprocal relationship from NCEL graph: Reciprocal relationship from SVRE g…
SVRE SaverOne 2014 Ltd. 72% oodwill Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in a business combination. We operate as a single reporting unit and test goodwill…
XTLB XTL Biopharmaceuticals Ltd. 72% oodwill Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in a business combination. We operate as a single reporting unit and test goodwill…
XTLB XTL Biopharmaceuticals Ltd. 72% Reciprocal relationship from XTLB graph: Reciprocal relationship from NCEL graph: Reciprocal relationship from XTLB graph: Reciprocal relationship from NCEL graph: oodwill Goodwill represents the exc…
BCLI Brainstorm Cell Therapeutics Inc. 62% Reciprocal relationship from BCLI graph: Reciprocal relationship from NCEL graph: Reciprocal relationship from BCLI graph: Reciprocal relationship from NCEL graph: Reciprocal relationship from BCLI g…

NewcelX Ltd. Debt Obligations

InstrumentDescriptionConfidenceEvidence
NCEL-DEBT-11189 Warrants outstanding: 1060574 90% xbrl warrant detail from xbrl 2025-12-31.
NCEL-DEBT-11190 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.
NCEL-DEBT Debt stack $355,000 90% Market cache reports total debt of $355,000.

NewcelX Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for NewcelX Ltd..

NewcelX Ltd. Ownership

HolderNameConfidenceEvidence
NCEL-OWNER-UBS-GROUP-AG UBS Group AG 90% 13F overlay lists UBS Group AG as top holder; 4 tracked holders.

NewcelX Ltd. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BCLI Brainstorm Cell Therapeutics Inc. 100.00 1 ['customer']
BSX Boston Scientific Corporation 100.00 2
CGC Canopy Growth Corporation 100.00 2
ALAR Alarum Technologies Ltd. 100.00 2
BWAY BrainsWay Ltd. 100.00 1 ['customer']
ELDN Eledon Pharmaceuticals, Inc. 100.00 1 ['customer']
INCR InterCure Ltd. 100.00 1 ['customer']
SNYNF Sanofi 100.00 2
SVRE SaverOne 2014 Ltd. 100.00 1 ['customer']
VWAV VisionWave Holdings, Inc. 100.00 2
XTLB XTL Biopharmaceuticals Ltd. 100.00 1 ['customer']
TLRY Tilray Brands, Inc. 50.00 2
ABT Abbott Laboratories 50.00 2
YEDA YEDA 50.00 2
RAMOT RAMOT 50.00 2
NIH NIH 50.00 2
TEVA Teva Pharmaceutical Industries Limited 50.00 2
NSRX Nasus Pharma Ltd. 50.00 2
NVSEF Novartis AG 50.00 2
ORANY ORANGE 50.00 2
🔐
NCEL
Unlock NCEL Supply Chain Data
Verified relationships include:
THIRD-PARTIESTHIRD-PARTIESSupplier85%
BWAYBrainsWay Ltd.Customer72%
BWAYBrainsWay Ltd.Customer72%
+12 more relationships locked
Subscribe, View plans →